Suchergebnisse - "Hu, Huabin"

PubPharm (156)

21

Distinct Clinicopathological Features and Prognostic Values of High-, Low-, or Non-Expressing HER2 Status in Colorectal Cancer

enthalten in: Cancers | 2023

von Wu, Z. | Cheng, Y. | Wang, H. | +12

22

canSAR : update to the cancer translational research and drug discovery knowledgebase

enthalten in: Nucleic acids research | 2023

von di Micco, P. | Antolin, A. | Mitsopoulos, C. | +10

23

Identification of differential polypharmacology between the PARP inhibitor rucaparib and its major metabolite

enthalten in: bioRxiv.org | 2022

von Hu, H. | Serra, C. | Llebaria, A. | +1

24

An ethnobotanical study on wild plants used by Tibetan people in Gyirong Valley, Tibet, China

enthalten in: Journal of ethnobiology and ethnomedicine | 2022

von Guo, C. | Ding, X. | Hu, H. | +3

25

An ethnobotanical study on wild plants used by Tibetan people in Gyirong Valley, Tibet, China

enthalten in: Journal of ethnobiology and ethnomedicine | 2022

von Guo, C. | Ding, X. | Hu, H. | +3

26

Locally advanced rectal mucinous adenocarcinoma : is preoperative radiation necessary?

enthalten in: Journal of gastrointestinal oncology | 2022

von Li, B. | Wu, K. | Li, J. | +7

27

Chemical Composition and Antifungal, Anti-Inflammatory, Antiviral, and Larvicidal Activities of the Essential Oils of Zanthoxylum acanthopodium DC. from China and Myanmar

enthalten in: Molecules (Basel, Switzerland) | 2022

von Yang, J. | Song, X. | Hu, H. | +4

28

Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy : A randomized, open-label, phase 3 trial

enthalten in: EClinicalMedicine | 2022

von Cheng, Y. | Wu, Z. | Shi, L. | +9

29

Prognostic impact of high-risk factors and KRAS mutation in patients with stage II deficient mismatch repair colon cancer : a retrospective cohort study

enthalten in: Annals of translational medicine | 2022

von Zhang, Y. | Wu, Z. | Zhang, B. | +6

CommentIn: Ann Transl Med. 2022 Sep;10(18):953. - PMID 36267788

30

The prognostic and predictive value of mismatch repair status in patients with locally advanced rectal cancer following neoadjuvant therapy

enthalten in: Annals of translational medicine | 2022

von Wu, Z. | Hu, H. | Wang, C. | +5

CommentIn: Ann Transl Med. 2022 Sep;10(18):951. - PMID 36267787